Skip to the page

Data / Form D filings / Rgenta Therapeutics, Inc.

Rgenta Therapeutics, Inc.: Form D filings

Rgenta Therapeutics, Inc., a technology company in Woburn, MA, filed 4 Form D notices with the SEC between 2020 and 2026. The latest, on November 3, 2026, reports $41.9 million sold of a $130.1 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
300 TradeCenter, Suite 6600, Woburn, MA, 01801
Phone
(781) 608-3996
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1801266

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 3, 2026New notice$130,107,279$41,852,307$88,254,9729Oct 19, 2026sec.gov
Feb 7, 2022New notice$8,914,283$8,914,2836Nov 9, 2021sec.gov
Mar 12, 2021Amendment$37,999,909$10,034,915$27,964,9946Jan 21, 2020sec.gov
Feb 5, 2020New notice$19,999,573$5,999,917$13,999,6564Jan 21, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Hualin Simon XiExecutive Officer, Director
Yichao FanDirector
Debasish RoychowdhuryDirector
Julia KaufmanDirector
Sean ZhangDirector, Promoter
Cillian KingDirector, Promoter
James KasuboskiDirector
Travis WagerExecutive Officer
Weng ZhipingDirector
Jeff GuckertExecutive Officer

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Nov 2, 2026 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Rgenta Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.